stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. KIDS
    stockgist
    HomeTop MoversCompaniesConcepts
    KIDS logo

    OrthoPediatrics Corp.

    KIDS
    NASDAQ
    Healthcare
    Medical - Devices
    Warsaw, IN, US562 employeesorthopediatrics.com
    $16.07
    -0.22(-1.34%)

    Mkt Cap $406M

    $15.20
    $23.68

    52-Week Range

    At a Glance

    AI-generated

    OrthoPediatrics Corp.

    Revenue breakdown: Traumaand Deformity (70.9%), Spine (27%), Sports Medicine And Other (2.1%).

    8-K
    OrthoPediatrics Corp. entered into a First Amendment to its existing Term Loan Agreement on March 31, 2026, establishing a new $20.0 million delayed draw term loan facility to provide incremental committed financing capacity.

    $406M

    Market Cap

    $253M

    Revenue

    -$43M

    Net Income

    Employees562
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Traumaand Deformity70.9%($418M)
    Spine27%($159M)
    Sports Medicine And Other2.1%($12M)

    Revenue by Geography

    US77.8%($459M)
    Non Us22.2%($131M)
    Activity

    What Changed Recently

    Material Agreement
    Mar 31, 2026

    above is incorporated by reference into this Item 2.03. ** ** | ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS. | |---|---| (d) Exhibits. | Exhibit No. | | Descr

    Financial Results
    Feb 25, 2026

    , including the information incorporated by reference herein from Exhibit 99.1, is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed “filed” f

    Financial Results
    Jan 11, 2026

    , including the information incorporated by reference herein from Exhibit 99.1, is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed "filed" f

    Regulation FD
    Feb 25, 2026

    , including the information incorporated by reference herein from Exhibit 99.1, is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed “filed” f

    Regulation FD
    Jan 11, 2026

    , including the information incorporated by reference herein from Exhibit 99.1, is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed “filed” f

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    EHABEnhabit, Inc.$13.99+0.18%$710M-150.1
    CBLLCeriBell, Inc.$18.57+0.35%$699M-13.2
    SRDXSRDX$42.98+0.35%$615M—
    BVSBioventus Inc.$8.96-2.02%$604M26.4
    LABStandard BioTools Inc.$0.91-0.90%$355M-5.0
    SMLRSMLR$20.33-4.87%$311M—
    TOIThe Oncology Institute, I...$3.13-0.16%$310M-53.7
    RXSTRxSight, Inc.$6.62+4.34%$273M-6.8
    Analyst View
    Company Profile
    CIK0001425450
    ISINUS68752L1008
    CUSIP68752L100
    Phone574 268 6379
    Address2850 Frontier Drive, Warsaw, IN, 46582, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice